期内，集团总GMV为238.3亿元，同比增长8.1%。Announcements on August 26, $YSB (09885.HK)$ According to the announcement, for the six months ended June 30, 2024, profit attributable to the company's owners was 21.82 million yuan (RMB, same below). The same period last year was a loss of 3.169 billion yuan, which turned a year-on-year loss into profit, with a profit of 0.03 yuan per share. There will be no interim dividend.
During the period, the Group's revenue was 8.814 billion yuan, up 10.61% year on year, and gross profit was 0.882 billion yuan, up 7.90% year on year.
According to the announcement, revenue from the Group's own business increased 10.9% to 8.345 billion yuan during the period, mainly due to the expansion of the buyer base and the continuous optimization of buyer experiences such as logistics and customer service; revenue from the platform business increased 10.9% to 8.345 billion yuan.
During the period, the Group's total GMV was 23.83 billion yuan, up 8.1% year-on-year.
As of June 30, 2024, the cumulative number of registered buyers exceeded 0.741 million, including about 0.426 million pharmacies and 0.31 million primary care institutions.
